SlideShare a Scribd company logo
1 of 11
COPD
INTRODUCTION
• COPD is a progressive respiratory condition characterized by
persistent airflow limitation, primarily caused by exposure to
harmful particles or gases, such as tobacco smoke.
• It encompasses two main conditions: chronic bronchitis and
emphysema.
• COPD is the fourth leading cause of death and affects >10 million
persons in the United States, about 250 million individuals with COPD
worldwide.
PATHOPHYSIOLOGY
•Exposure to harmful gases, triggers an inflammatory response in
the airways, leading to tissue damage and narrowing of the air
passages.
•Chronic bronchitis a clinically defined condition that involves
inflammation of the bronchial tubes, leading to excessive phlegm
production and cough.
•Emphysema an anatomically defined condition that involves
destruction of the alveoli with air space enlargement, resulting in
decreased lung elasticity and airflow limitation.
PATHOGENESIS OF
EMPHYSEMA
α1 Antitrypsin
Deficiency
DIAGNOSIS
•Diagnosis typically involves pulmonary function tests, including
spirometry, to assess lung function and severity of airflow
limitation.
•Additional tests such as chest X-rays or CT scans may be
utilized to assess lung structure and rule out other conditions.
•Diagnosis is confirmed when a patient exhibits a post-
bronchodilator forced expiratory volume in one second
(FEV1)/forced vital capacity (FVC) ratio less than 0.70.
GOLD CRITERIA
TREATMENT
APPROACHES
•Pharmacological interventions include bronchodilators (beta-agonists,
anticholinergics), corticosteroids (oral/inhaled), PDE-4 inhibitors and
Azithromycin to alleviate symptoms and reduce exacerbation risk.
•Non-pharmacological interventions such as smoking cessation,
pulmonary rehabilitation, oxygen therapy and vaccination against
influenza and pneumococcus are crucial components of COPD
management.
•Surgical options like LVRS (lung volume reduction surgery) or lung
transplantation may be considered in severe cases.
SEVERITY ASSESSMENT
A FEW WORD ON
EXACERBATION
• Defined by worsening of the respiratory symptoms- dyspnea,
cough, weezing and character of suptum
• More then 50% of exacerbations caused due to bacterial or viral
infections
• A comprehensive assesment of change in respiratory symptoms
and worsening of dyspnea. Also fever, nausea, vomiting,
diarrhea, myalgia and chills.
INITAIL TREATMENT
FOLLOW UP
TREATMENT

More Related Content

Similar to chronic obstructive pulmonary disease management

Similar to chronic obstructive pulmonary disease management (20)

COPD:CLINICAL REVIEW AND ANESTHESIA CONSIDERATION
COPD:CLINICAL REVIEW AND ANESTHESIA CONSIDERATIONCOPD:CLINICAL REVIEW AND ANESTHESIA CONSIDERATION
COPD:CLINICAL REVIEW AND ANESTHESIA CONSIDERATION
 
Power point pulmonary pathophysiology - v.1
Power point   pulmonary pathophysiology - v.1Power point   pulmonary pathophysiology - v.1
Power point pulmonary pathophysiology - v.1
 
Copd ppt
Copd pptCopd ppt
Copd ppt
 
Copd
CopdCopd
Copd
 
CHRONIC OBSTRUCTIVE PULMONARY DISEASE BY AKRAM KHAN
CHRONIC OBSTRUCTIVE PULMONARY DISEASE BY AKRAM KHANCHRONIC OBSTRUCTIVE PULMONARY DISEASE BY AKRAM KHAN
CHRONIC OBSTRUCTIVE PULMONARY DISEASE BY AKRAM KHAN
 
Chronic obstructive pulmonary disease
Chronic obstructive pulmonary diseaseChronic obstructive pulmonary disease
Chronic obstructive pulmonary disease
 
COPD
COPDCOPD
COPD
 
COPD.pptx
COPD.pptxCOPD.pptx
COPD.pptx
 
file_1631791130_0007343_LT-5.pptx
file_1631791130_0007343_LT-5.pptxfile_1631791130_0007343_LT-5.pptx
file_1631791130_0007343_LT-5.pptx
 
Copd phenotypes
Copd phenotypesCopd phenotypes
Copd phenotypes
 
Chronic obstructive pulmunary disease DR. Parshant
Chronic obstructive pulmunary disease DR. ParshantChronic obstructive pulmunary disease DR. Parshant
Chronic obstructive pulmunary disease DR. Parshant
 
COPD (Chronic obstructive pulmonary disease )
COPD (Chronic obstructive pulmonary disease )COPD (Chronic obstructive pulmonary disease )
COPD (Chronic obstructive pulmonary disease )
 
Medical Management and Perioperative Assessment of Respiratory Diseases
Medical Management and Perioperative Assessment of Respiratory DiseasesMedical Management and Perioperative Assessment of Respiratory Diseases
Medical Management and Perioperative Assessment of Respiratory Diseases
 
COPD-Report.pdf
COPD-Report.pdfCOPD-Report.pdf
COPD-Report.pdf
 
RESPIRATORY DISTURBANCE.pptx
RESPIRATORY DISTURBANCE.pptxRESPIRATORY DISTURBANCE.pptx
RESPIRATORY DISTURBANCE.pptx
 
2 COPD.ppt
2  COPD.ppt2  COPD.ppt
2 COPD.ppt
 
01.copd
01.copd01.copd
01.copd
 
COPD
COPDCOPD
COPD
 
COPD.pptx
COPD.pptxCOPD.pptx
COPD.pptx
 
COPD chronic obstructive pulmonary disease
COPD chronic obstructive pulmonary diseaseCOPD chronic obstructive pulmonary disease
COPD chronic obstructive pulmonary disease
 

Recently uploaded

Sonia Journal club presentation (2).pptx
Sonia Journal club presentation (2).pptxSonia Journal club presentation (2).pptx
Sonia Journal club presentation (2).pptx
palsonia139
 
CAS 110-63-4 BDO Liquid 1,4-Butanediol 1 4 BDO Warehouse Supply For Excellent...
CAS 110-63-4 BDO Liquid 1,4-Butanediol 1 4 BDO Warehouse Supply For Excellent...CAS 110-63-4 BDO Liquid 1,4-Butanediol 1 4 BDO Warehouse Supply For Excellent...
CAS 110-63-4 BDO Liquid 1,4-Butanediol 1 4 BDO Warehouse Supply For Excellent...
ocean4396
 
Connective Tissue II - Dr Muhammad Ali Rabbani - Medicose Academics
Connective Tissue II - Dr Muhammad Ali Rabbani - Medicose AcademicsConnective Tissue II - Dr Muhammad Ali Rabbani - Medicose Academics
Connective Tissue II - Dr Muhammad Ali Rabbani - Medicose Academics
MedicoseAcademics
 
Failure to thrive in neonates and infants + pediatric case.pptx
Failure to thrive in neonates and infants  + pediatric case.pptxFailure to thrive in neonates and infants  + pediatric case.pptx
Failure to thrive in neonates and infants + pediatric case.pptx
claviclebrown44
 

Recently uploaded (20)

Sonia Journal club presentation (2).pptx
Sonia Journal club presentation (2).pptxSonia Journal club presentation (2).pptx
Sonia Journal club presentation (2).pptx
 
Unlocking Holistic Wellness: Addressing Depression, Mental Well-Being, and St...
Unlocking Holistic Wellness: Addressing Depression, Mental Well-Being, and St...Unlocking Holistic Wellness: Addressing Depression, Mental Well-Being, and St...
Unlocking Holistic Wellness: Addressing Depression, Mental Well-Being, and St...
 
ESC HF 2024 Spotlights Day-2.pptx heart failure
ESC HF 2024 Spotlights Day-2.pptx heart failureESC HF 2024 Spotlights Day-2.pptx heart failure
ESC HF 2024 Spotlights Day-2.pptx heart failure
 
CONGENITAL HYPERTROPHIC PYLORIC STENOSIS by Dr M.KARTHIK EMMANUEL
CONGENITAL HYPERTROPHIC PYLORIC STENOSIS  by Dr M.KARTHIK EMMANUELCONGENITAL HYPERTROPHIC PYLORIC STENOSIS  by Dr M.KARTHIK EMMANUEL
CONGENITAL HYPERTROPHIC PYLORIC STENOSIS by Dr M.KARTHIK EMMANUEL
 
Sell pmk powder cas 28578-16-7 from pmk supplier Telegram +85297504341
Sell pmk powder cas 28578-16-7 from pmk supplier Telegram +85297504341Sell pmk powder cas 28578-16-7 from pmk supplier Telegram +85297504341
Sell pmk powder cas 28578-16-7 from pmk supplier Telegram +85297504341
 
HIFI* ℂall Girls In Thane West Phone 🔝 9920874524 🔝 💃 Me All Time Serviℂe Ava...
HIFI* ℂall Girls In Thane West Phone 🔝 9920874524 🔝 💃 Me All Time Serviℂe Ava...HIFI* ℂall Girls In Thane West Phone 🔝 9920874524 🔝 💃 Me All Time Serviℂe Ava...
HIFI* ℂall Girls In Thane West Phone 🔝 9920874524 🔝 💃 Me All Time Serviℂe Ava...
 
Varicose Veins Treatment Aftercare Tips by Gokuldas Hospital
Varicose Veins Treatment Aftercare Tips by Gokuldas HospitalVaricose Veins Treatment Aftercare Tips by Gokuldas Hospital
Varicose Veins Treatment Aftercare Tips by Gokuldas Hospital
 
CAS 110-63-4 BDO Liquid 1,4-Butanediol 1 4 BDO Warehouse Supply For Excellent...
CAS 110-63-4 BDO Liquid 1,4-Butanediol 1 4 BDO Warehouse Supply For Excellent...CAS 110-63-4 BDO Liquid 1,4-Butanediol 1 4 BDO Warehouse Supply For Excellent...
CAS 110-63-4 BDO Liquid 1,4-Butanediol 1 4 BDO Warehouse Supply For Excellent...
 
Premium ℂall Girls In Mumbai👉 Dail ℂALL ME: 📞9833325238 📲 ℂall Richa VIP ℂall...
Premium ℂall Girls In Mumbai👉 Dail ℂALL ME: 📞9833325238 📲 ℂall Richa VIP ℂall...Premium ℂall Girls In Mumbai👉 Dail ℂALL ME: 📞9833325238 📲 ℂall Richa VIP ℂall...
Premium ℂall Girls In Mumbai👉 Dail ℂALL ME: 📞9833325238 📲 ℂall Richa VIP ℂall...
 
ANAPHYLAXIS BY DR.SOHAN BISWAS,MBBS,DNB(INTERNAL MEDICINE) RESIDENT.pptx
ANAPHYLAXIS BY DR.SOHAN BISWAS,MBBS,DNB(INTERNAL MEDICINE) RESIDENT.pptxANAPHYLAXIS BY DR.SOHAN BISWAS,MBBS,DNB(INTERNAL MEDICINE) RESIDENT.pptx
ANAPHYLAXIS BY DR.SOHAN BISWAS,MBBS,DNB(INTERNAL MEDICINE) RESIDENT.pptx
 
Connective Tissue II - Dr Muhammad Ali Rabbani - Medicose Academics
Connective Tissue II - Dr Muhammad Ali Rabbani - Medicose AcademicsConnective Tissue II - Dr Muhammad Ali Rabbani - Medicose Academics
Connective Tissue II - Dr Muhammad Ali Rabbani - Medicose Academics
 
The Orbit & its contents by Dr. Rabia I. Gandapore.pptx
The Orbit & its contents by Dr. Rabia I. Gandapore.pptxThe Orbit & its contents by Dr. Rabia I. Gandapore.pptx
The Orbit & its contents by Dr. Rabia I. Gandapore.pptx
 
Quality control tests of suppository ...
Quality control tests  of suppository ...Quality control tests  of suppository ...
Quality control tests of suppository ...
 
Let's Talk About It: Ovarian Cancer (The Emotional Toll of Treatment Decision...
Let's Talk About It: Ovarian Cancer (The Emotional Toll of Treatment Decision...Let's Talk About It: Ovarian Cancer (The Emotional Toll of Treatment Decision...
Let's Talk About It: Ovarian Cancer (The Emotional Toll of Treatment Decision...
 
Failure to thrive in neonates and infants + pediatric case.pptx
Failure to thrive in neonates and infants  + pediatric case.pptxFailure to thrive in neonates and infants  + pediatric case.pptx
Failure to thrive in neonates and infants + pediatric case.pptx
 
DR. Neha Mehta Best Psychologist.in India
DR. Neha Mehta Best Psychologist.in IndiaDR. Neha Mehta Best Psychologist.in India
DR. Neha Mehta Best Psychologist.in India
 
Hemodialysis: Chapter 1, Physiological Principles of Hemodialysis - Dr.Gawad
Hemodialysis: Chapter 1, Physiological Principles of Hemodialysis - Dr.GawadHemodialysis: Chapter 1, Physiological Principles of Hemodialysis - Dr.Gawad
Hemodialysis: Chapter 1, Physiological Principles of Hemodialysis - Dr.Gawad
 
Results For Love Spell Is Guaranteed In 1 Day +27834335081 [BACK LOST LOVE SP...
Results For Love Spell Is Guaranteed In 1 Day +27834335081 [BACK LOST LOVE SP...Results For Love Spell Is Guaranteed In 1 Day +27834335081 [BACK LOST LOVE SP...
Results For Love Spell Is Guaranteed In 1 Day +27834335081 [BACK LOST LOVE SP...
 
ROSE CASE SPINAL SBRT BY DR KANHU CHARAN PATRO
ROSE  CASE SPINAL SBRT BY DR KANHU CHARAN PATROROSE  CASE SPINAL SBRT BY DR KANHU CHARAN PATRO
ROSE CASE SPINAL SBRT BY DR KANHU CHARAN PATRO
 
NDCT Rules, 2019: An Overview | New Drugs and Clinical Trial Rules 2019
NDCT Rules, 2019: An Overview | New Drugs and Clinical Trial Rules 2019NDCT Rules, 2019: An Overview | New Drugs and Clinical Trial Rules 2019
NDCT Rules, 2019: An Overview | New Drugs and Clinical Trial Rules 2019
 

chronic obstructive pulmonary disease management

  • 2. INTRODUCTION • COPD is a progressive respiratory condition characterized by persistent airflow limitation, primarily caused by exposure to harmful particles or gases, such as tobacco smoke. • It encompasses two main conditions: chronic bronchitis and emphysema. • COPD is the fourth leading cause of death and affects >10 million persons in the United States, about 250 million individuals with COPD worldwide.
  • 3. PATHOPHYSIOLOGY •Exposure to harmful gases, triggers an inflammatory response in the airways, leading to tissue damage and narrowing of the air passages. •Chronic bronchitis a clinically defined condition that involves inflammation of the bronchial tubes, leading to excessive phlegm production and cough. •Emphysema an anatomically defined condition that involves destruction of the alveoli with air space enlargement, resulting in decreased lung elasticity and airflow limitation.
  • 5. DIAGNOSIS •Diagnosis typically involves pulmonary function tests, including spirometry, to assess lung function and severity of airflow limitation. •Additional tests such as chest X-rays or CT scans may be utilized to assess lung structure and rule out other conditions. •Diagnosis is confirmed when a patient exhibits a post- bronchodilator forced expiratory volume in one second (FEV1)/forced vital capacity (FVC) ratio less than 0.70.
  • 7. TREATMENT APPROACHES •Pharmacological interventions include bronchodilators (beta-agonists, anticholinergics), corticosteroids (oral/inhaled), PDE-4 inhibitors and Azithromycin to alleviate symptoms and reduce exacerbation risk. •Non-pharmacological interventions such as smoking cessation, pulmonary rehabilitation, oxygen therapy and vaccination against influenza and pneumococcus are crucial components of COPD management. •Surgical options like LVRS (lung volume reduction surgery) or lung transplantation may be considered in severe cases.
  • 9. A FEW WORD ON EXACERBATION • Defined by worsening of the respiratory symptoms- dyspnea, cough, weezing and character of suptum • More then 50% of exacerbations caused due to bacterial or viral infections • A comprehensive assesment of change in respiratory symptoms and worsening of dyspnea. Also fever, nausea, vomiting, diarrhea, myalgia and chills.